These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3759538)

  • 21. Time without symptoms and toxicity (TWIST) analysis of adjuvant radiation therapy for endometrial cancer.
    Jereczek-Fossa BA; Badzio A; Jassem J
    Radiother Oncol; 2004 Aug; 72(2):175-81. PubMed ID: 15297136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simple method to calculate the influence of dose inhomogeneity and fractionation in normal tissue complication probability evaluation.
    Begnozzi L; Gentile FP; Di Nallo AM; Chiatti L; Zicari C; Consorti R; Benassi M
    Strahlenther Onkol; 1994 Oct; 170(10):590-4. PubMed ID: 7974170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic factors of the probability of the occurrence of complications in the radiation therapy of malignant neoplasms].
    Pavlov AS; Datsenko VS; Fadeeva MA; Zamiatin OA; Kizhaev EV
    Vopr Onkol; 1980; 26(3):3-8. PubMed ID: 7368653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Probabilities of organs at risk damage: history and mathematical models].
    Rezvoy N; Dubray B
    Cancer Radiother; 2010 Jul; 14(4-5):241-5. PubMed ID: 20598614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interactive determination of the parameters of mathematical models for planning radiotherapy of malignant tumors. I. Mathematical models for calculating dose tolerance, adequate doses and the likelihood of development of radiation complications in normal organs and tissues].
    Klepper LIa
    Med Tekh; 2000; (4):37-41. PubMed ID: 10984881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A statistical study on the survival rate].
    Fukuhisa K; Takeda E
    Gan No Rinsho; 1985 Sep; 31(12):1621-31. PubMed ID: 4079052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating the age-at-onset function using life-table methods.
    Chidambaram A; Chakravarti A; Ferrell RE; Iyengar S
    Genet Epidemiol; 1988; 5(4):255-63. PubMed ID: 3169528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer.
    Mantz CA; Song P; Farhangi E; Nautiyal J; Awan A; Ignacio L; Weichselbaum R; Vijayakumar S
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):551-7. PubMed ID: 9112452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response-probability volume histograms and iso-probability of response charts in treatment plan evaluation.
    Mavroidis P; Ferreira BC; Lopes Mdo C
    Med Phys; 2011 May; 38(5):2382-97. PubMed ID: 21776773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preliminary results of treatment of solid tumors in children with non-standard radiotherapy].
    Glekov IV; Koshechkina NA; Ivanova NM
    Vopr Onkol; 1997; 43(4):443-5. PubMed ID: 9381701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The atlas of complication incidence: a proposal for a new standard for reporting the results of radiotherapy protocols.
    Jackson A; Yorke ED; Rosenzweig KE
    Semin Radiat Oncol; 2006 Oct; 16(4):260-8. PubMed ID: 17010909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization of radiation therapy, III: A method of assessing complication probabilities from dose-volume histograms.
    Lyman JT; Wolbarst AB
    Int J Radiat Oncol Biol Phys; 1987 Jan; 13(1):103-9. PubMed ID: 3804804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of intraluminal brachytherapy dose on complications in the treatment of esophageal cancer.
    Kumar MU; Swamy K; Supe SS; Anantha N
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1069-72. PubMed ID: 8262829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prophylactic postoperative radiotherapy in the treatment of supraglottic tumors].
    Esposito E; Motta S; Cassiano B; Motta G
    Acta Otorhinolaryngol Ital; 2000 Dec; 20(6):432-41. PubMed ID: 11398681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using percolation networks to incorporate spatial-dose information for assessment of complication probability in radiotherapy.
    Gale N; House M; Ebert MA
    Australas Phys Eng Sci Med; 2017 Dec; 40(4):869-880. PubMed ID: 29199375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Normal tissue reactions and complications following high-energy neutron beam therapy. II: Complication rates adjusted for censoring.
    Schultheiss TE; Cohen L; Mansell J
    Int J Radiat Oncol Biol Phys; 1990 Jan; 18(1):165-71. PubMed ID: 2105285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local control and complications after radiation therapy for primary orbital lymphoma: a case for low-dose treatment.
    Minehan KJ; Martenson JA; Garrity JA; Kurtin PJ; Banks PM; Chen MG; Earle JD
    Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):791-6. PubMed ID: 2004956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regarding actuarial late effect analyses: Bentzen et al., IJROBP 32:1531-1534; 1995 and Caplan et al., IJROBP 32:1547; 1995.
    Denham JW; Hamilton CS; O'Brien P
    Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):197. PubMed ID: 8641920
    [No Abstract]   [Full Text] [Related]  

  • 40. Survival in radiation myelopathy.
    Schultheiss TE; Stephens LC; Peters LJ
    Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1765-9. PubMed ID: 3759528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.